Actionnariat et activité des initiés pour Maravai LifeSciences Holdings, Inc. (MRVI): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $6.84 |
| Capitalisation | $1.9B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-08 | Brust Bernd | F-InKind | 29,250 | $214K |
| 2026-08-31 | Asarpota Rajesh | F-InKind | 5,465 | $42K |
| 2026-08-10 | Brust Bernd | F-InKind | 29,250 | $182K |
| 2026-07-30 | Asarpota Rajesh | F-InKind | 5,465 | $36K |
| 2026-07-08 | Brust Bernd | F-InKind | 29,250 | $173K |
| 2026-06-30 | Asarpota Rajesh | F-InKind | 65,584 | $419K |
| 2026-06-08 | Brust Bernd | F-InKind | 351,001 | $1.8M |
| 2026-06-09 | ORESHACK KURT | S-Sale | 25,000 | $126K |
| 2026-06-10 | ORESHACK KURT | S-Sale | 25,000 | $127K |
| 2026-06-09 | LUCIER GREGORY T | G-Gift | 46,293 |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $21.9M | $24.7M | $236.2M | $551.3M | $632.1M | $575.0M | $322.4M | $216.9M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $16.0M | $18.0M | $51.0M | $117.5M | $146.8M | $55.7M | $38.5M | $25.5M |
| Stocks | $14.3M | $14.2M | $33.3M | $51.6M | $43.2M | $51.4M | $50.1M | $40.5M |
| Actifs Courants | $53.8M | $60.6M | $331.6M | $740.0M | $847.9M | $699.9M | $429.1M | $296.3M |
| Immobilisations Corporelles | $42.6M | $94.3M | $101.3M | $95.4M | $116.6M | $222.6M | $217.0M | $1.2M |
| Goodwill | $224.3M | $224.3M | $224.3M | $152.8M | $283.7M | $326.0M | $159.9M | $129.4M |
| Actifs Incorporels | $218.1M | $197.9M | $177.7M | $117.6M | $216.7M | $221.0M | $195.0M | $151.5M |
| Actifs Totaux | $539.7M | $577.8M | $1.27B | $1.92B | $2.28B | $1.49B | $1.01B | $770.6M |
| Dettes Fournisseurs | $3.6M | $7.5M | $3.0M | $8.2M | $6.0M | $10.7M | $12.0M | 0 |
| Dette à Court Terme | $2.5M | $2.5M | $6.0M | $6.0M | $5.4M | $5.4M | $5.4M | $5.4M |
| Passifs Courants | $35.9M | $29.6M | $130.8M | $93.8M | $110.1M | $87.5M | $57.0M | $44.9M |
| Dette à Long Terme | $335.6M | $334.8M | $528.6M | $524.6M | $522.0M | $518.7M | $290.5M | $30.1M |
| Passifs Totaux | $391.7M | $433.2M | $1.12B | $1.37B | $1.38B | $697.6M | $431.0M | $397.9M |
| Réserves | -$38.2M | -$42.4M | $854000 | $184.6M | $404.8M | $285.7M | $140.9M | $10.1M |
| Capitaux Propres | $144.4M | $141.4M | $88.5M | $315.5M | $545.2M | $416.8M | $325.3M | $212.4M |
| Dette Totale | $339.9M | $390.2M | $590.8M | $575.2M | $585.3M | $611.0M | $376.7M | $35.6M |
| Dette Nette | $318.0M | $365.5M | $354.6M | $23.9M | -$46.9M | $36.0M | $54.3M | -$181.3M |
| Fonds de Roulement | $17.9M | $31.0M | $200.8M | $646.3M | $737.8M | $612.4M | $372.2M | $251.3M |
Santé financière
| Dette / Capitaux propres | 0.86 |
| Ratio de liquidité | 4.05 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 1.98 |
Rentabilité
| Rentabilité des capitaux propres | -61.58% |
| Rentabilité du capital investi | -0.91% |
| Rentabilité des actifs | -16.97% |
| Marge brute | 34.61% |
| Marge opérationnelle | 46.02% |
| Marge nette | -37.07% |
Entreprises liées: BCAX · DNA · IOVA · KURA · LENZ · PRME · REPL
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de MRVI: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions